Transforming the clinical management of Multiple Sclerosis patients trough machine intelligence
Our current technology is based on three innovative AI private modules (normalization, continuous learning and lesion inference) and a visual interface module. The lesion inference module is licensed exclusively from the VHIR and UDG institutions. The normalization and continuous learning modules are property of Tensor Medical, and we plan to patent them in 2024-2025. The visual interface is the only module that is public and is accessible to users to validate the results.
Under evaluation at least till: July 13th, 2022